Received Apr 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Z008441 | SC / RA |
The patient is a 59 y/o F who presents to clinic with concern of sore throat for 2 weeks. She also subsequently developed a generalized rash that started on her trunk, then moved to her face and extremities. She denies cough, rhinorrhea, nasal congestion, or conjunctivitis. No current fever. She has not started any new medications recently, but she did receive a dose of the MMR vaccine at the end of March. She did travel to the city recently but is unaware of any sick contacts.
NA
Inflammatory polyarthropathy, Connective tissue disease, undifferentiated, Inflammatory arthritis
adalimumab-atto (Amjevita(CF)) 40 mg/0.4 mL Syringe INJECT 1 SYRINGE SUBCUTANEOUSLY WEEKLY amLODIPine (Norvasc) 5 mg tablet TAKE 1 TABLET BY MOUTH EVERY DAY ascorbic acid/collagen hydr (COLLAGEN PLUS VITAMIN C ORAL) Take by mouth. aspirin
Bethanechol, Wheat
Rapid Strep -Negative, Measles Antibody, IgM - Positive, Measles Virus PCR, Urine - Negative, Send Out/Measels PCR - Not Resulted yet, Respiratory Viral Panel PCR - Negative